|
|
||||||||


* Departamento de Producción Animal, Facultad de Veterinaria, Universidad de León, 24071 León, Spain
Consorcio de Promoción del Ovino, 49630-Villalpando, Zamora, Spain
1 Corresponding author: c.gonzalo{at}unileon.es
| ABSTRACT |
|---|
|
|
|---|
Key Words: ovine milk screening test detection limit antimicrobial residue
| INTRODUCTION |
|---|
|
|
|---|
The European Union (EU) determines the limits for the presence of specified veterinary residues in milk. The antimicrobial residues are defined by Council Regulation EEC 2377/90 (EU, 1990), although a number of amendments have subsequently been made to extend the list of agents with maximum residue limits (MRL) established.
Increasing awareness of public health and food safety issues in recent years has lead to a greater interest in milk quality. To determine the presence of AR in cow milk, several rapid screening tests have been developed to test milk on the farm or in milk plants (IDF, 1991); recently, interest in research into AR detection is growing in dairy sheep (Berruga et al., 2003; Yamaki et al., 2004). As intensification of milk production in small ruminants has increased in recent years, the use of antimicrobial substances in dairy ewes has become a usual practice in veterinary medicine to treat mastitis and other diseases. In addition, the shortage of specific commercial formulations for dairy ewes makes it necessary to use antibiotic preparations normally used in cattle, the withdrawal period of which is undefined in ewes milk. Within an AR testing program in this species, a broad study on AR detection methods is needed to guarantee residue levels in milk below the established EU-MRL. Validation of tests is essential for selection of the most appropriate testing strategies, estimation of predictive values, appropriate test interpretation, and to ensure that testing programs operate as efficiently as possible (Gardner, 1997). The first results obtained from the BRT-AiM (AIM-Analytik in Milch Producktions-und Vertriebs GmbH, Munich, Germany; Althaus et al., 2001; Molina et al., 2003), Delvotest-SP (DSM Food Specialities, Delft, the Netherlands; Althaus et al., 2003), and Eclipse-100ov (ZEU-Immunotec, Zaragoza, Spain; Montero, 2004) tests in detecting AR in ovine milk demonstrated low sensitivity and high variability of those methods, particularly for no-β-lactam AR.
The blue-yellow method (BY) is a broad-spectrum microbial inhibition assay for cow milk AR detection, and it is not well known in countries of the European Union. This simple and easy-to-read screening test gives results within a relatively short period (<3 h). Results of the BY test are classified visually into 3 categories: "negative," "doubtful," and "positive" compared with reference colors. According to manufacturers instructions, the detection limits (DL) of this test for some macrolides, aminoglycosides, tetracyclines, and sulfonamides are close to MRL, and an attempt should be made to evaluate the tests performance in ovine milk.
Thus, the evaluation of this method for ovine milk could be of interest in programs for AR detection, and this study should increase the information about the performance of AR detection methods in dairy sheep. The aim of this research was to calculate the BY DL for 25 antimicrobial agents belonging to 6 different families in ovine milk.
| MATERIALS AND METHODS |
|---|
|
|
|---|
500 x 103 cells/mL. Milk samples were analyzed during the 4-h period after collection by BY test (Charm Sciences Inc., Lawrence, MA), which is a microbial growth inhibition assay intended for use on bulk tank milk and individual animal samples. After the addition of 50 µL of milk into single wells containing spores of Geobacillus stearothermophilus var. calidolactis ATCC 10149 strain, plates were incubated at 65°C for 2 h 45 min. Visual interpretation of results was carried out by comparison with a color table and evaluated as negative, doubtful, or positive.
In accordance with the IDF indications (IDF, 1999), 8 concentrations were prepared for each drug in the proximity of the test detection level. A previous study using dilutions (1:10) between 100 mg/kg and 0.1 µg/kg was carried out as a first approximation to DL for each antimicrobial agent. For each concentration, 20 replicates were prepared using 20 different antibiotic-free milk samples obtained from individual animals. The number of different individual milk samples was 125 (each sample was used to test the 8 concentrations of each drug in 4 different drugs). Samples were collected on the day of testing. The number of antimicrobial agents studied was 25, from 6 antimicrobial families. The list of drugs included 3 penicillins (penicillin G, ampicillin, cloxacillin), 3 cephalosporins (cefoperazone, cephalexin, and ceftiofur), 4 aminoglycosides (gentamycin, neomycin, framycetin, and streptomycin), 4 macrolides (tylosin, tilmicosin, spyramicin, and erythromycin), 4 tetracyclines (tetracycline, doxicycline, oxytetracycline, and chlortetracycline), 4 sulfonamides (sulfadimethoxine, sulfathiazole, sulfamethazine, sulfanilamide), and 3 quinolones (enrofloxacine, flumequine, and danofloxacine). Table 1
summarizes the antimicrobial agents and the concentrations used. These drugs were stored and handled according to the manufacturers instructions before being used. Drugs were dissolved (1 mg/mL) in water, except ceftiofur (dissolved in Tris-HCl, 100 mM, pH 9); sulfanilamide, tetracycline, chlortetracycline, and oxytetracycline (dissolved in methanol); and erythromycin (dissolved in ethanol). The pH were adjusted with KOH or HCl. Final concentrations in milk (µg/kg) were achieved after serial dilutions in such a way that the volume of the antimicrobial agent solution did not exceed 1% of the volume of the final solution to be analyzed. In this study, the total number of observations was 4,000 (25 drugs x 8 concentrations x 20 replicates).
|
Statistical Analyses
The DL of antimicrobial agents were estimated by a logistic regression model using the LOGISTIC procedure of SAS (SAS Institute, 1998). For this model, the response was considered as ordinal with 3 possible values, which corresponded to positive, doubtful, and negative results. The logistic regression model used was
![]() |
where logit = lineal logistic model; i.e., ln [Pij/(1 – Pij)]; Pij = probability of positive vs. doubtful + negative results, on the one hand, and positive + doubtful vs. negative results, on the other hand; AC = antimicrobial concentration; a = intercept; b = slope; and
ij = residual error. In this study, 2 intercept coefficients were obtained: a01, for the estimation of frequency of positive vs. doubtful + negative results, and a02, for the estimation of frequency of positive + doubtful vs. negative results. The concordance coefficients were also estimated. This coefficient was applied as rank correlation between observed and predicted results (Althaus et al., 2003). This model included all possible categorical results and provided 2 DL for each antimicrobial agent. The DL of visual interpretation for BY test was estimated as the concentration at which 95% of results were positive. Sensitivity was defined as the antimicrobial concentration that was detected by BY test.
According to Ortega et al. (1995), reproducibility between observers was evaluated by means of kappa value defined as (OP – EP)/(1 – EP), where OP = observed concordance between observers, and EP = random predicted concordance.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Table 2
summarizes the statistical and DL values. Two DL values were found for each antimicrobial agent: DL1 for comparison between positive vs. doubtful + negative results, and DL2 for comparison between positive + doubtful vs. negative results. The concordance percentages of logistic regression were high (85.7 to 97.7%; Table 2
) illustrating the good correlation achieved between observed and predicted results by logistic regression.
|
The coefficient b (slope) of logistic regression is a parameter closely related to the screening test sensitivity for each antimicrobial agent. A smaller b coefficient produced greater DL values and consequently less BY sensitivity for any antimicrobial agent. The lowest b values were for quinolones (0.0002 to 0.003) and the greatest values were for penicillin G (4.6) and ampicillin (3.03; Table 2
).
The b parameter reached greater values for β-lactams than for the other chemotherapeutics assayed. The DL calculated for penicillin G (3 to 4 µg/kg) and ceftiofur (96 to 107 µg/kg) were similar to or below EU-MRL (4 and 100 µg/kg, respectively). The DL for ampicillin (5 to 6 µg/kg), cloxacillin (33 to 42 g/kg), cefoperazone (73 to 82 µg/kg), and cefalexin (160 to 202 µg/kg) were greater than EU-MRL (4, 30, 50, and 100 µg/kg). These DL were very similar to found by other authors using the BRT, Eclipse-100ov or Delvotest-SP screening tests in ovine milk (Althaus et al., 2001, 2003; Montero, 2004), although the DL for penicillin (1 µg/kg) and cephalexin (40 µg/kg) were lower in the Delvotest-SP test (Althaus et al., 2003). β-Lactams can be effective against gram-positive pathogens and they are frequently used in mastitis therapies for dairy sheep (Marco, 1994; Molina et al., 2003, Linage et al., 2007), so a detection program for β-lactams in milk has been implemented in the main dairy sheep basins (i.e., Eclipse 100ov method in Castilla y León, Spain).
Framycetin (720 to 781 µg/kg) and neomycin (915 to 1,084 µg/kg) had DL lower than those found by using the Delvotest-SP (2,600 µg/kg), BRT-AiM (3,700 µg/kg), and Eclipse-100ov (9,100 µg/kg) tests for neomycin in ovine milk (Althaus et al., 2003; Molina et al., 2003; Montero, 2004). Results for framycetin using other tests than BY are unknown in ovine milk. In addition, the DL for gentamycin (355 to 382 µg/kg) and streptomycin (3,063 to 3,593 µg/kg) were also lower than those obtained by using the Delvotest-SP, BRT-AiM, or Eclipse-100ov tests (1,200 to 1,950 µg/kg for gentamycin, and 6,100 to 10,000 µg/kg for streptomycin; Althaus et al., 2003; Molina et al., 2003; Montero, 2004). Consequently, BY had greater sensitivity than other screening tests for detecting aminoglycosides. Nevertheless, only DL for neomycin and framycetin obtained by BY in ovine milk were lower than EU-MRL (1,500 µg/kg). This screening test is not appropriate, however, for gentamycin (EU-MRL: 100 µg/kg) or streptomycin (EU-MRL: 200 µg/kg), which showed the lowest b values (0.37 and 0.03). Neomycin and framycetin are antimicrobial agents used in mastitis treatments (i.e., ewe dry therapies) because of their effectiveness against gram-negative organisms, so the high sensitivity showed for BY in detecting these drugs must be emphasized.
Within the macrolides, only tylosin (44 to 51 µg/kg) showed a DL very close to EU-MRL (50 µg/kg), but the DL for tilmicosin (109 to 131 µg/kg), erythromycin (444 to 522 µg/kg), and spyramicin (1,106 to 1,346 µg/kg) were greater than EU-MRL (50, 40, and 200 µg/kg, respectively). Althaus et al. (2003) and Montero (2004) reported greater DL for tylosin (100 to 220 µg/kg), erythromycin (700 to 980 µg/kg), and spyramicin (15,500 µg/kg) when using the Eclipse-100ov and Delvotest-SP tests in ovine milk. As a result, BY showed a great sensitivity for macrolides compared with the abovementioned screening tests, but only tylosin could be detected at concentrations below or at the EU-MRL. Tylosin is an antibiotic developed for veterinary use with a variable activity again gram-positive and mycoplasma organisms. It is frequently used for contagious agalactia treatment in enzootic areas in case of clinical outbreaks (i.e., Mediterranean countries), and consequently, detection programs based on an appropriate screening test should be established.
Results obtained by using BY for tetracyclines demonstrated that this test was more sensitive for tetracycline with a DL (233 to 257 µg/kg) greater than EU-MRL (100 µg/kg) but lower than DL obtained by using Eclipse-100ov (480 µg/kg), Delvotest-SP (590 µg/kg), or BRT-AiM (6,200 µg/kg; Althaus et al., 2003; Montero, 2004; Molina et al., 2003). The BY test had a sensitivity similar to other methods for doxycycline (323 to 419 µg/kg), a very improved sensitivity for oxytetracycline (398 to 501 µg/kg) compared with the BRT-AiM test (5,500 µg/kg; Molina et al., 2003), and a low sensitivity for chlortetracycline (3,331 to 3,989 µg/kg). Nevertheless, the tetracycline family, and particularly chlortetracycline, showed DL clearly separate from EU-MRL (100 µg/kg).
The DL for sulfadimethoxine (101 to 119 µg/kg) was slightly greater than EU-MRL (100 µg/kg). Sulfathiazole (122 to 151 µg/kg), sulfamethazine (309 to 328 µg/kg), and particularly sulfanilamide (1,750 to 2,674 µg/kg) had DL greater than EU-MRL (100 µg/kg). The sulfonamides were better detected by BY than by other screening tests such as Eclipse-100ov (170 to 750 µg/kg), except for sulfanilamide, which was better detected by the Eclipse-100ov test (370 µg/kg; Montero, 2004). The BRT-AiM test DL for the sulfonamide family (3,200 to 6,500 µg/kg; Molina et al., 2003) were much greater than those obtained by the BY test.
The DL for quinolones (4.7 to 71 mg/kg; Table 2
) were much greater than EU-MRL (30 to 100 µg/kg) and similar to results reported for the Eclipse-100ov test (3.7 to 90 mg/kg; Montero, 2004).
Comparing our results with those obtained by using other screening tests, it must be emphasized that there are important differences among methods for antimicrobial DL, particularly for several aminoglycosides, macrolides, and sulfonamides, despite the fact that all these methods use microbial inhibitor procedures based on inhibition of spore outgrowth of G. stearothermophilus var. calidolactis. In this sense, different performances among methods cannot be fully explained by differences in strain types used in each test (i.e., BY and Eclipse tests are based on the same strain of G. stearothermophilus: ATCC 10149). Thus, the concentration of organisms within individual wells and the properties of the gel or culture medium in which the organisms are placed could be important in increasing the sensitivity of the screening test, but this information is not available.
This study was carried out in individual Assaf milk samples and in midlactation. Early lactation is also an important period for an increased risk of antibiotic residues, but some screening tests can show high rates of false-positive outcomes in colostrum. A previous study using BY to evaluate the residue status in colostrum demonstrated a BY specificity rate of 0.966 in Assaf ewes (Linage et al., 2007). This is an increased rate compared with other screening tests used in dairy cattle (Andrew, 2001), so BY could be used in early and midlaction in dairy sheep.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication March 29, 2007. Accepted for publication August 27, 2007.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Sierra, A. Contreras, A. Sanchez, C. Luengo, J. C. Corrales, C. T. Morales, C. de la Fe, I. Guirao, and C. Gonzalo Short communication: Detection limits of non-{beta}-lactam antibiotics in goat's milk by microbiological residues screening tests J Dairy Sci, September 1, 2009; 92(9): 4200 - 4206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sierra, A. Sanchez, A. Contreras, C. Luengo, J. C. Corrales, C. T. Morales, C. de la Fe, I. Guirao, and C. Gonzalo Detection limits of four antimicrobial residue screening tests for {beta}-lactams in goat's milk J Dairy Sci, August 1, 2009; 92(8): 3585 - 3591. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gonzalo, B. Linage, J. A. Carriedo, M. T. Juarez, E. Beneitez, A. Martinez, and L. F. De La Fuente Short communication: Effect of dry therapy using an intramammary infusion on bulk tank somatic cell count in sheep J Dairy Sci, January 1, 2009; 92(1): 156 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Linage and C. Gonzalo Influence of an Intramammary Infusion at Drying-Off of Combined Penethamate Hydriodide, Benethamine Penicillin, and Framycetin Sulfate on Intramammary Infections and Somatic Cell Counts in Dairy Sheep J Dairy Sci, September 1, 2008; 91(9): 3459 - 3466. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |